CHAMPIONS ONCOLOGY, INC.

Profile

Company Names

CHAMPIONS ONCOLOGY, INC.
CHAMPIONS BIOTECHNOLOGY, INC.

Addresses

ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK, NJ 07601

855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD 21205

SCIENCE AND TECHNOLOGY PARK AT JOHNS HOP, 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD 21205

Phone Numbers

201-808-8400
410-369-0365

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$36,808,501.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2015-03-13 
$14,000,000.00 
$14,000,000.00 
$0.00 
Equity 
7
2014-12-01 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
6
2013-01-28 
$9,300,000.00 
$9,300,000.00 
$0.00 
Equity 
5
2012-02-08 
$8,500.00 
$8,500.00 
$0.00 
Equity 
4
2011-04-04 
$9,400,000.00 
$9,400,000.00 
$0.00 
Equity 
3
2011-03-25 
$1.00 
$1.00 
$0.00 
Equity 
2
2010-10-25 
$0.00 
INDEFINITE 
INDEFINITE 
 
1
2009-12-21 
$2,100,000.00 
$10,000,000.00 
$7,900,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOEL 
 
ACKERMAN 
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS 
D. 
BURKETT, PH.D. 
EXECUTIVE OFFICER
ARTHUR 
 
EPKER, III 
DIRECTOR
GARY 
 
GEMIGNANI 
EXECUTIVE OFFICER
JAMES 
M. 
MARTELL 
DIRECTOR, PROMOTER
JAMES 
 
MCGORRY 
EXECUTIVE OFFICER
DANIEL 
 
MENDELSON 
DIRECTOR
DAVID 
 
MILLER 
EXECUTIVE OFFICER
CAZENOVE EUROPEAN EQUITY ABSOLUTE RETURN FUND LTD   |  CAZENOVE EUROPEAN ALPHA ABSOLUTE RETURN FUND LTD   |  SANDRINGHAM LONG/SHORT FUND II   |  PK JAPAN   |  STRATHMORE MINERALS CORP.   |  AZIMA HOLDINGS INC   |  PK JAPAN LONG   |  CASTLE HILL TOTAL RETURN FUND LLC   |  TEXAS MULTICORE TECHNOLOGIES, INC.   |  COMMERCE NATIONAL FINANCIAL SERVICES, INC.   |  CASTLE HILL TOTAL RETURN FUND LTD   |  IROQUOIS VALLEY FARMS LLC   |  SONATYPE INC   |  ARMAJARO STS COMMODITIES FUND LTD   |  CAPEVIEW AZRI 2X FUND   |  CAPEVIEW AZRI FUND   |  CAPEVIEW RECOVERY FUND   |  ELLINGTON RESIDENTIAL MORTGAGE REIT   |  NORTHSTAR ALARM HOLDINGS LLC   |  HERO VENTURES LLC   |  ELEMENT ROBOT LLC   |  DECLAN RESOURCES INC.   |  TMG ENERGY CORP.   |  CHAMPIONS ONCOLOGY, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  CLARUS HOLDINGS, LLC   |  CLARUS PARENT HOLDINGS, LLC   |  EMERGE DIAGNOSTICS, INC   |  QUEST FUELS MANAGEMENT, LLC   |  BROOKHAVEN PROGRESS FUND, LLC   |  PESSEGO LONG SHORT FUND, LP   |  CLEAN ENERGY VENTURE FUND I, LP   |  IROQUOIS VALLEY FARMLAND REIT, PBC   |  SONATYPE, INC   |  PIKA ENERGY, INC.   |  NORTH HAVEN TV FEEDER FUND LP   |  NORTH HAVEN TACTICAL VALUE FUND LP   |  FLOWR CORP   |  BACKYARD CAPITAL FUND II, LLC   |  MACULOGIX, INC.   |  PLS INC.   |  AJR PHYSICIAN HOLDINGS, LLC   |  TOCA FOOTBALL, INC.   |  BOSTON MATERIALS, INC.   |  DELINEO DIAGNOSTICS, INC.   |  WEST STREET STRATEGIC SOLUTIONS FUND I, L.P.   |  WEST STREET STRATEGIC SOLUTIONS OFFSHORE FUND I, L.P.   |  WEST STREET STRATEGIC SOLUTIONS OFFSHORE FEEDER FUND I, LLC   |  WEST STREET CO-INVESTMENT PARTNERS (C), L.P.   |  WEST STREET STRATEGIC SOLUTIONS FUND I-(C), L.P.   |  ALX RESOURCES CORP.   |  EVIDENCE TOPCO LTD   |  CYGNUS-AI INC.   |  VOLEXION, INC.   |  RENEW DIGITAL HOLDINGS, LLC   |  TULA HEALTH, INC.   |  SMARTPAY FUND II, LLC   |  1869 PRIVATE OPPORTUNITIES PARTNERS I, LP   |  CLEAN ENERGY VENTURE FUND II, LP   |  GOLDMAN SACHS MIDDLE MARKET LENDING CORP. II   |  NORTH HAVEN TACTICAL VALUE FUND II LP   |  MSTV FUND II EMPLOYEES LP   |  NGTF REIT DE, LLC   |  VISIONARY GOLD CORP.   |  VISIONARY METALS CORP.   |  NUCLEAR FUELS INC.   |  RABBU, INC.   |  1GT FUND (LUX) SCSP   |  NORTH HAVEN VENTURE CAPITAL OPPORTUNITIES FUND I LP   |  NORTH HAVEN VENTURE CAPITAL OPPORTUNITIES FUND I (CAYMAN) LP   |  TANGENESIS, INC.   |  CATALYST ENHANCED SYSTEMATIC ALPHA FUND LP   |  ANSERINE LABS, INC.
RONNIE 
 
MORRIS 
EXECUTIVE OFFICER, DIRECTOR
RONNIE 
 
MORRIS, M.D. 
EXECUTIVE OFFICER, DIRECTOR
ABBA 
D. 
POLIAKOFF 
DIRECTOR
ABBA 
DAVID 
POLIAKOFF 
DIRECTOR
MARK 
R. 
SCHONAU 
EXECUTIVE OFFICER
DAVID 
 
SIDRANKSKY 
DIRECTOR
DAVID 
 
SIDRANSKY, M.D. 
DIRECTOR, PROMOTER
ANA 
 
STANCIC 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2015-03-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Debt 
2014-12-01 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$5,000,001 - $25,000,000 
Equity 
2013-01-28 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2012-02-08 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2011-04-04 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2011-03-25 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
 
2010-10-25 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2009-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MTS SECURITIES, LLC
GREGORY J. BERLACHER
EMERGING GROWTH EQUITIES